Delivery Order SPE2DB20D3103-SPE2DB21FM1E8
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $7,022.60 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide pharmaceutical products and medical supplies. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of medical commodities to the Department of...
- This federal contract award is for a prime vendor pharmaceutical delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, valued at $3,930.33. The contract was awarded by the Defense Logistics Agency (DLA) and supports DLA Troop Support Medical operations. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award is for a Prime Vendor Pharmaceutical delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,139.40 delivery order is a firm-fixed-price contract that supports the DLA Troop Support Medical program. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,591.79 delivery order contract is for a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has a firm fixed price pricing type and an ultimate completion date of April 14,...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $13,080.00, is for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,420.20 delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of a wide range of pharmaceutical products and medical supplies to support Defense Logistics Agency (DLA) Troop Support Medical. The $12,338.50 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA. This single-award IDC serves as the primary vehicle for the company to provide critical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $25,031.92, is a delivery order that falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, worth up to $999,999,999.00. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,343.76, is a delivery order under an Indefinite Delivery Contract (IDC) the company holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,569.96 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FM1E8Delivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The $13,414.22 delivery order is for a prime vendor pharmaceutical contract supporting the DLA Troop Support Medical division. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities and veteran healthcare programs worldwide. The contract covers essential medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. This particular delivery order does not have a set-aside designation, indicating full and open competition. Amerisourcebergen's parent company, Cencora, Inc., also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 1/12/21 |